DRUG · Unmapped registry intervention
CagriSema
Find medicine records ·
Find other trials using this name
Clinical trial
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
NCT07817251
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedResearch Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
CagriSemaDRUG
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
HoustonTexas, United States1Los AngelesCalifornia, United States1DallasTexas, United States1San AntonioTexas, United States1NashvilleTennessee, United States1San DiegoCalifornia, United States1AustinTexas, United States1Salt Lake CityUtah, United States1Las VegasNevada, United States1SacramentoCalifornia, United States1La JollaCalifornia, United States1AlbuquerqueNew Mexico, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07817251 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.